Anti-IL6-Receptor Tocilizumab in Refractory and Noninfectious Uveitic Cystoid Macular Edema: Multicenter Study of 25 Patients

Causes and frequency of blindness in patients with intraocular inflammatory disease.

Aniki Rothová, M S Suttorp-van Schulten, W F Treffers et al. · British Journal of Ophthalmology · 1996 · 902 citations · Full text

Medicine, Ophthalmology, Ocular Disease +13

Standardizatlon of Vitreal inflammatory Activity in Intermediate and Posterior Uveitis

Robert B. Nussenblatt, Alan G. Palestine, Chi‐Chao Chan et al. · Ophthalmology · 1985 · 681 citations

Medicine, Ophthalmology, Inflammation +13

Vitreous Levels of Interleukin-6 and Vascular Endothelial Growth Factor in Macular Edema with Central Retinal Vein Occlusion

Hidetaka Noma, Hideharu Funatsu, Tatsuya Mimura et al. · Ophthalmology · 2008 · 230 citations · Full text

Medicine, Immunology, Ophthalmology +16

Primary (Month-6) Outcomes of the STOP-Uveitis Study: Evaluating the Safety, Tolerability, and Efficacy of Tocilizumab in Patients With Noninfectious Uveitis

Yasir J. Sepah, Mohammad Ali Sadiq, David Chu et al. · American Journal of Ophthalmology · 2017 · 161 citations

Pharmacy, Immunology, Pharmacotherapy +10

Anti–Interleukin‐6 Receptor Tocilizumab for Severe Juvenile Idiopathic Arthritis–Associated Uveitis Refractory to Anti–Tumor Necrosis Factor Therapy: A Multicenter Study of Twenty‐Five Patients

V. Calvo-Río, Inmaculada Calvo, María Isabel González et al. · Arthritis & Rheumatology · 2016 · 152 citations

Medicine, Ophthalmology, Pharmacotherapy +17